Fulcrum Therapeutics Inc.

NASDAQ: FULC · Real-Time Price · USD
6.81
0.21 (3.18%)
At close: Aug 15, 2025, 3:59 PM
6.82
0.15%
After-hours: Aug 15, 2025, 04:10 PM EDT

Fulcrum Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-29.96 -4.25 -3.1 -7.99
PEG Ratio
0.34 0.13 -0.53 0.45
PS Ratio
3.64 147.54 51.65 32.64
PB Ratio
1.20 1.76 1.65 2.96
P/FCF Ratio
-116.72 -4.52 -3.31 -7.8
P/OCF Ratio
-131.35 -4.55 -3.37 -7.97
OCF/S Ratio
-0.03 -32.43 -15.3 -4.1
Debt / Equity Ratio
0.04 0.05 0.07 n/a
Quick Ratio
22.63 17.71 12.46 11.80
Current Ratio
22.63 17.71 12.41 11.77
Asset Turnover
0.31 0.01 0.03 0.08
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.04 -0.41 -0.53 -0.37
Return on Assets
-0.04 -0.38 -0.47 -0.33
Return on Invested Capital
-0.09 -0.45 -0.5 -0.36
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.98 1.00 0.62 0.87
Net Profit Margin
-0.12 -34.7 -16.65 -4.09
Pretax Profit Margin
-0.12 -34.7 -17.32 -4.22
Operating Profit Margin
-0.27 -39.45 -17.75 -4.23
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.23 -38.68 -17.3 -4.1